Coherus BioSciences (CHRS) Earnings Date, Estimates & Call Transcripts → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free CHRS Stock Alerts $2.12 -0.05 (-2.30%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 7EstimatedActual EPS (May. 9) -$0.38 Missed By -$0.33 Consensus EPS (May. 9) -$0.05 Read Call TranscriptListen to Call Get Coherus BioSciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for CHRS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCHRS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CHRS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Coherus BioSciences Analyst EPS EstimatesNext Year EPS Consensus Estimate: ($0.06) EPSCHRS Earnings Date and InformationCoherus BioSciences last issued its quarterly earnings data on May 9th, 2024. The biotechnology company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.33. The company earned $77.06 million during the quarter, compared to analysts' expectations of $102 million. Coherus BioSciences has generated ($0.78) earnings per share over the last year (($0.78) diluted earnings per share). Coherus BioSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.Read More Coherus BioSciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/7/2024Estimated)------- 5/9/2024Q1 2024($0.05)($0.38)($0.33)($1.59)$102.00 million$77.06 million 3/13/2024Q4 2023($0.33)($0.72)($0.39)($0.73)$105.30 million$91.52 million11/6/2023Q3 2023($0.45)($0.38)+$0.07($0.35)$80.13 million$74.57 million8/2/2023Q2 2023($0.66)($0.49)+$0.17($0.49)$50.83 million$58.72 million5/8/2023Q1 2023($0.77)($0.89)($0.12)($0.82)$50.73 million$32.44 million3/6/2023Q4 2022($0.64)($0.76)($0.12)($0.76)$45.72 million$45.35 million Get the Latest News and Ratings for CHRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022($0.79)($1.11)($0.32)($1.11)$57.23 million$45.42 million8/4/2022Q2 2022($0.96)($0.65)+$0.31($0.65)$58.00 million$60.15 million 5/5/2022Q1 2022($0.80)($1.24)($0.44)($1.24)$68.07 million$60.12 million2/17/2022Q4 2021($0.61)($0.60)+$0.01($0.60)$83.32 million$73.37 million 11/7/2021Q3 2021($0.22)($0.34)($0.12)($0.49)$86.96 million$82.50 million 8/5/2021Q2 2021($0.25)($0.40)($0.15)($0.40)$82.65 million$87.64 million Coherus BioSciences Earnings - Frequently Asked Questions When is Coherus BioSciences's earnings date? Coherus BioSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on CHRS's earnings history. Did Coherus BioSciences beat their earnings estimates last quarter? In the previous quarter, Coherus BioSciences (NASDAQ:CHRS) missed the analysts' consensus estimate of ($0.05) by $0.33 with a reported earnings per share (EPS) of ($0.38). Learn more on analysts' earnings estimate vs. CHRS's actual earnings. How can I listen to Coherus BioSciences's earnings conference call? The conference call for Coherus BioSciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Coherus BioSciences's conference call transcript? The conference call transcript for Coherus BioSciences's latest earnings report can be read online. Read Transcript How much revenue does Coherus BioSciences generate each year? Coherus BioSciences (NASDAQ:CHRS) has a recorded annual revenue of $257.24 million. How much profit does Coherus BioSciences generate each year? Coherus BioSciences (NASDAQ:CHRS) has a recorded net income of -$237.89 million. CHRS has generated -$0.78 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: MGX Earnings GLUE Earnings AGEN Earnings ZURA Earnings CMPX Earnings ABOS Earnings STRO Earnings INMB Earnings PSTX Earnings IPSC Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:CHRS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coherus BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
